Envestnet Asset Management Inc Sarepta Therapeutics, Inc. Transaction History
Envestnet Asset Management Inc
- $299 Billion
- Q1 2025
A detailed history of Envestnet Asset Management Inc transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Envestnet Asset Management Inc holds 37,359 shares of SRPT stock, worth $1.46 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
37,359
Previous 45,614
18.1%
Holding current value
$1.46 Million
Previous $5.55 Million
57.01%
% of portfolio
0.0%
Previous 0.0%
Shares
32 transactions
Others Institutions Holding SRPT
# of Institutions
508Shares Held
88.9MCall Options Held
1.39MPut Options Held
1.13M-
Black Rock Inc. New York, NY10.3MShares$405 Million0.04% of portfolio
-
Capital International Investors Los Angeles, CA9.06MShares$355 Million0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.03MShares$354 Million0.01% of portfolio
-
State Street Corp Boston, MA4.07MShares$160 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X03.36MShares$132 Million0.12% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $3.43B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...